Neurofarm Pharmaceuticals S.L. (manufacturing in bulk, primary and secondary packaging, quality control, responsible for batch release)

Ukraine

All drugs from this manufacturer

  • SOLECTIS

    The drug is used for the symptomatic treatment of frequent urination, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.

    Dosage form: tablets, film-coated

    Active substance Dosage
    solifenacin 3.8 mg

    ATC: G04BD08

  • SOLESIS

    The drug is used for the symptomatic treatment of urinary urgency, urinary incontinence, and other symptoms characteristic of overactive bladder syndrome.

    Dosage form: tablets, film-coated

    Active substance Dosage
    solifenacin 7.5 mg

    ATC: G04BD08